rs147962315
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4BS2
The NM_006243.4(PPP2R5A):c.565G>A(p.Val189Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000192 in 1,612,240 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006243.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PPP2R5A | ENST00000261461.7 | c.565G>A | p.Val189Ile | missense_variant | Exon 4 of 13 | 1 | NM_006243.4 | ENSP00000261461.2 | ||
| PPP2R5A | ENST00000537030.3 | c.394G>A | p.Val132Ile | missense_variant | Exon 4 of 13 | 2 | ENSP00000442866.1 | |||
| PPP2R5A | ENST00000479259.1 | n.732G>A | non_coding_transcript_exon_variant | Exon 5 of 5 | 5 | |||||
| PPP2R5A | ENST00000498129.6 | n.737G>A | non_coding_transcript_exon_variant | Exon 6 of 6 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152000Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000320 AC: 8AN: 250164 AF XY: 0.0000370 show subpopulations
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1460240Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 8AN XY: 726386 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152000Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74234 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.565G>A (p.V189I) alteration is located in exon 4 (coding exon 4) of the PPP2R5A gene. This alteration results from a G to A substitution at nucleotide position 565, causing the valine (V) at amino acid position 189 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at